SCHEMBL6959565

SCHEMBL6959565

COC(=O)c1ccc2[nH]cc(CCCCN3CCCC(Cc4ccccc4)C3)c2c1

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.63
SLC6A4 P31645 4/20 0.52
ADRA2A P08913 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
HTR1D P28221 1/20 0.49
HTR1B P28222 1/20 0.49
KDM4E B2RXH2 1/20 0.49
ALOX15 P16050 1/20 0.49
APEX1 P27695 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
GPR84 Q9NQS5 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7879034 0.93 HTR1A (0.55) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL7879009 0.93 HTR1A (0.55) HTR1ASLC6A4
SCHEMBL7880274 0.93 HTR1A (0.55) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL7880351 0.92 HTR1A (0.54) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL7881308 0.92 ADRA2A (0.58) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL6947723 0.91 KDM4E (0.58) HTR1ASLC6A4HTR1DHTR1BKDM4E
SCHEMBL7881273 0.90 HTR1A (0.53) HTR1ASLC6A4
SCHEMBL27417126 0.89 HTR1A (0.55) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL6958383 0.88 HTR1A (0.52) HTR1ASLC6A4ADRA2AADRA2BADRA2C
SCHEMBL6954556 0.86 HTR1A (0.60) HTR1ASLC6A4ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993458-B1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 2003-04-09 EP claimed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US claimed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US disclosed